60
Participants
Start Date
April 23, 2024
Primary Completion Date
April 18, 2026
Study Completion Date
October 18, 2026
Nanobody-based biepitope BCMA-targeting CAR-T cells
Each patient will receive nanobody-based biepitope BCMA-targeting CAR-T cell by intravenous infusion on day 0.
RECRUITING
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan
Hebei Taihe Chunyu Biotechnology Co., Ltd
INDUSTRY
Huazhong University of Science and Technology Union Shenzhen Hospital
UNKNOWN
The Seventh Affiliated Hospital of Sun Yat-sen University
OTHER
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
OTHER